Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough
.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28679467)

Published in Int J Clin Pharmacol Ther on July 06, 2017

Authors

Jaclyn A Smith, Lorcan P A McGarvey, Huda Badri, Imran Satia, Francis Warren, Sarah Siederer, Lia Liefaard, Robert D Murdoch, Kathryn Povey, Joanna Marks-Konczalik

Articles by these authors

Predictors of objective cough frequency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.64

Increased tachykinin levels in induced sputum from asthmatic and cough patients with acid reflux. Thorax (2007) 1.25

Considerations in developing and delivering a nonpharmacological intervention for symptom management in lung cancer: the views of patients and informal caregivers. J Pain Symptom Manage (2012) 1.20

Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD. Pulm Pharmacol Ther (2012) 1.19

Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med (2007) 1.15

Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin. J Biol Chem (2003) 1.07

The mechanics of airway closure. Respir Physiol Neurobiol (2008) 1.02

Chronic cough: relationship between microaspiration, gastroesophageal reflux, and cough frequency. Chest (2012) 1.01

STAT-1 and c-Fos interaction in nitric oxide synthase-2 gene activation. Am J Physiol Lung Cell Mol Physiol (2003) 0.98

General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review. Chest (2011) 0.95

Social complexity in bees is not sufficient to explain lack of reversions to solitary living over long time scales. BMC Evol Biol (2007) 0.95

A comparison of objective and subjective measures of cough in asthma. J Allergy Clin Immunol (2008) 0.93

Gabapentin for refractory chronic cough. Lancet (2013) 0.92

Evaluation of oral corticosteroids and phosphodiesterase-4 inhibitor on the acute inflammation induced by inhaled lipopolysaccharide in human. Pulm Pharmacol Ther (2006) 0.92

Cough hypersensitivity syndrome is an important clinical concept: a pro/con debate. Lung (2011) 0.90

Impaired lung function and health status in adult survivors of bronchopulmonary dysplasia. Eur Respir J (2013) 0.89

Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end point. J Allergy Clin Immunol (2013) 0.84

Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis. Eur Respir J (2012) 0.83

Quality of life in patients with chronic cough. Ther Adv Respir Dis (2010) 0.82

A causal relationship between cough and gastroesophageal reflux disease (GERD) has been established: a pro/con debate. Lung (2013) 0.81

The efficacy of a NOP1 agonist (SCH486757) in subacute cough. Lung (2010) 0.81

Cross-sectional association of dietary patterns with asthma and atopic sensitization in childhood - in a cohort study. Pediatr Allergy Immunol (2014) 0.80

Targeting TRP channels for chronic cough: from bench to bedside. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.80

TRPV1 inhibition does not prevent cold dry air-elicited symptoms in non-allergic rhinitis. Int J Clin Pharmacol Ther (2014) 0.79

Patient misreporting may lead to underestimation of cough events. Chest (2007) 0.79

Data reduction for cough studies using distribution of audio frequency content. Cough (2012) 0.79

Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough. Cough (2010) 0.79

The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis. Int J Clin Pharmacol Ther (2013) 0.79

Objective measurement of cough in otherwise healthy volunteers with acute cough. Eur Respir J (2012) 0.77

The Manchester cough in lung cancer scale: the development and preliminary validation of a new assessment tool. J Pain Symptom Manage (2012) 0.77

Once-daily dosing of levocabastine has comparable efficacy to twice-daily dosing in the treatment of allergic rhinitis assessed in an allergen challenge chamber. Int J Clin Pharmacol Ther (2015) 0.76

Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendations. Nucleic Acid Ther (2012) 0.76

Breaking the sound barrier? Pitfalls and benefits of acoustic cough monitoring. Am J Gastroenterol (2012) 0.75

PCR based bronchoscopic detection of common respiratory pathogens in chronic cough: a case control study. Cough (2012) 0.75

The importance of being earnest; in haemostasis after femoral venepuncture. BMJ Case Rep (2011) 0.75

Clinical pharmacology of Cilomilast. Clin Pharmacokinet (2006) 0.75

Clinical posters discussion: summary. Pulm Pharmacol Ther (2010) 0.75

Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers. Clin Ther (2006) 0.75

Population pharmacokinetics of inhaled fluticasone furoate and vilanterol in adult and adolescent patients with asthma. Int J Clin Pharmacol Ther (2016) 0.75

Personalised Medicine for Asthma and Chronic Obstructive Pulmonary Disease. Respiration (2017) 0.75

Pharmacologic therapy for cough. Curr Opin Pharmacol (2011) 0.75

Children must be protected from the tobacco industry's marketing tactics. BMJ (2013) 0.75